CHONGQING, CHINA - JULY 29: In this photo illustration, a smartphone displays the logo of Moderna Inc. (NASDAQ: MRNA), a biotechnology company known for its mRNA-based vaccines and therapeutics, in front of a screen showing the company's latest stock market chart on July 29, 2025 in Chongqing, China. (Photo illustration by Cheng Xin/Getty Images)Getty ImagesModerna stock surged 16% yesterday after receiving promising clinical trial results for its experimental skin cancer vaccine. The firm is working on mRN ...